DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Johnson - 2 Johnson Covid - 2 Janssen - 1 De Telegraaf - 1 Tesla - 1 Abbott - 1 Zions - 1 Estee Lauder - 1
Top related locs:
Los Angeles Netherlands Los Angeles , California China Freeport
Top related orgs:
Netflix - 1 Refinitiv - 1 American Airlines – - 1 American Airlines - 1 IBM - 1 Johnson - 1 Dow Jones - 1 Abbott - 1

Search resuls for: "Johnson COVID"


5 mentions found


☆ J&J's Janssen to close part of its vaccine division
  + stars: | 2023-08-23 | by ( ) www.cnbc.com   time to read: 1 min
Johnson & Johnson Covid-19 vaccines are seen on a table in Los Angeles, May 7, 2021. Johnson & Johnson 's Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported. In an emailed response on Wednesday, Johnson & Johnson confirmed plans to exit some of its vaccine research and development programs, which it said it had initially disclosed in its 2023 second-quarter results. "We also continually assess our global footprint, including in the Netherlands, to ensure it meets our current and evolving scientific needs," Johnson & Johnson said. De Telegraaf reported that 2,500 people worked at Janssen in the Netherlands, a quarter of which were in the section specialising in infectious diseases and vaccines.
Persons: Johnson, Johnson Covid, Janssen, De Telegraaf Locations: Los Angeles, Netherlands
☆ Stocks making the biggest moves midday: Netflix, American Airlines, Johnson & Johnson and more
  + stars: | 2023-07-20 | by ( Hakyung Kim | Https | Www.Linkedin.Com In Hakyungkim | ) www.cnbc.com   time to read: +4 min
Johnson & Johnson Covid-19 vaccines are seen on a table on May 7, 2021 in Los Angeles, California. Johnson & Johnson —The stock jumped 6%, lifting the 30-stock Dow Jones Industrial Average, after the the health care posted second-quarter revenue and adjusted earnings that topped Wall Street's expectations. Johnson & Johnson also lifted its full-year guidance as sales from the company's medtech business jumped. Discover Financial Services — Shares tumbled 14% after the company's second-quarter results missed analysts' estimates on both top and bottom lines. MarketAxess — The electronic trading platform rallied 5.6% after releasing its second-quarter results.
Persons: Johnson, Johnson Covid, Tesla, Abbott, Zions, Estee Lauder, StreetAccount, —, Yun Li, Jesse Pound, Samantha Subin, Michelle Fox Organizations: Netflix, Refinitiv, American Airlines –, American Airlines, IBM, Johnson, Dow Jones, Abbott, Discover Financial, Federal Deposit Insurance, Barclays Locations: Los Angeles , California, China, Freeport
☆ FDA says two studies showing omicron boosters weren't much better than old Covid shots were too small to come to any conclusions
  + stars: | 2022-10-28 | by ( Spencer Kimball | ) www.cnbc.com   time to read: +6 min
The recently authorized booster vaccine protects against the original SARS-CoV-2 virus and the more recent omicron variants, BA.4 and BA.5. The Food and Drug Administration said two studies this week showing that the new omicron boosters weren't that much better than the old shots were too small to come to any real conclusions. The antibody responses were slightly higher with the omicron boosters, though the studies concluded the difference wasn't significant. The studies are of public interest because there's very limited human data on how the omicron BA.5 boosters perform right now. The FDA also looked at data directly on the BA.5 shots that came from animal studies.
☆ New Covid boosters aren’t better than old shots at neutralizing omicron BA.5, early studies find
  + stars: | 2022-10-27 | by ( Spencer Kimball | ) www.cnbc.com   time to read: +3 min
The new COVID-19 booster which includes protection for Omicron at AltaMed Health Services in South Gate on Thursday, October 6, 2022. Two studies are raising doubts about whether the new omicron BA.5 booster really will offer better protection against Covid than the first generation shot. Scientists at Columbia University in New York City found the new boosters did not produce a better antibody response in humans against BA.5 than the first-generation vaccines. Hotez said there should also be investigations into how the boosters perform against emerging omicron subvariants such as XBB and BQ.1., as the currently dominant BA.5 declines in circulation. It could be the case that the new boosters perform better against these emerging variants than the first generation shots do, Hotez said.
☆ Updated Covid-19 boosters offer protection, but new studies suggest they don't offer an edge against Omicron
  + stars: | 2022-10-26 | by ( Brenda Goodman | ) edition.cnn.com   time to read: +13 min
Similar immune responsesThe studies have important limitations, and they aren’t the final word on the updated boosters. In Barouch’s study, antibody concentrations were 15 times higher after the original boosters, rising from 184 to 2,829. They were 17 times higher after the updated shots, jumping from 211 to 3,693. After waiting the recommended three months since his last Covid-19 infection, President Joe Biden got an updated booster Tuesday and urged eligible Americans to do the same. Worobey says that when the strains are combined as they are in the updated boosters, they actually end up competing.
0 next >>
Total: 5